Whalen Wealth Management Inc. Buys New Stake in Axon Enterprise, Inc $AXON

Whalen Wealth Management Inc. bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 896 shares of the biotechnology company’s stock, valued at approximately $502,000.

Several other institutional investors and hedge funds have also bought and sold shares of AXON. Cibc World Market Inc. acquired a new position in shares of Axon Enterprise during the second quarter worth $4,202,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of Axon Enterprise during the 2nd quarter valued at $2,168,000. Osmosis Investment Management UK Ltd purchased a new stake in shares of Axon Enterprise during the 2nd quarter valued at $7,260,000. Sanctuary Advisors LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth $1,757,000. Finally, Barbara Oil Co. acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth $2,046,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of AXON opened at $597.59 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The company’s fifty day moving average price is $546.20 and its 200-day moving average price is $478.02. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29. The firm has a market capitalization of $48.55 billion, a PE ratio of 247.96, a price-to-earnings-growth ratio of 10.19 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same quarter last year, the business posted $2.12 EPS. The firm’s quarterly revenue was up 35.3% on a year-over-year basis. On average, equities research analysts predict that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Insiders Place Their Bets

In related news, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. The trade was a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 76,594 shares of company stock valued at $41,236,386. Insiders own 4.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on AXON shares. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Barclays boosted their price target on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, UBS Group upped their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.